Genomic diagnostics company Veracyte Inc (Nasdaq: VCYT) disclosed on Tuesday that it has appointed Sangeeta Bhorade, MD to the role of medical director of pulmonology.
Dr Bhorade, who is is board certified in pulmonary and critical care medicine, will lead medical affairs for Veracyte's pulmonology products that include Percepta Bronchial Classifier and Envisia Genomic Classifier. She will report to Veracyte's chief scientific and medical officer, Giulia Kennedy, PhD.
Previously, Dr Bhorade served as professor of medicine and the medical director of the Lung Transplant Program in the Pulmonary and Critical Care Division at Northwestern University Feinberg School of Medicine, where she launched its Lung Transplant Program and provided research and clinical expertise as a principal faculty member of the Interstitial Lung Disease Program.
In addition, Dr Bhorade initiated the Lung Transplant Program at the University of Chicago and served as its medical director.
Convergent Therapeutics names new chairman of board of directors
Ionis Pharmaceuticals names new executive vice president, chief global product strategy officer
Cardinal Health names new independent director
Micron Biomedical names new scientific advisor to CEO
MedPharm names new executive chairman
Armonica Technologies names new director
Jazz Pharmaceuticals names new executive vice president and chief financial officer
Jazz Pharmaceuticals names new executive vice president and chief financial officer
Ardigen names new chief commercial officer
AbbVie names new chief executive officer
AMO Pharma collaborates with Population Health Research Institute for tideglusib clinical trial